Qiagen (QGEN) Financials

$40.70 -0.74 (-1.79%)

Closing price 04/17/2025 03:59 PM Eastern

Extended Trading

$40.70 +0.01 (+0.02%)

As of 04/17/2025 04:32 PM Eastern

Annual Income Statements for Qiagen

This table shows Qiagen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	116	130	80	40	190	-41	359	513	423	341	84
Consolidated Net Income / (Loss)	117	130	80	40	190	-41	359	513	423	341	84
Net Income / (Loss) Continuing Operations	117	130	80	40	190	-41	359	513	423	341	84
Total Pre-Tax Income	119	136	57	114	226	-78	439	626	513	430	121
Total Operating Income	162	179	99	153	267	-26	386	630	531	410	98
Total Gross Profit	865	827	845	923	1,001	1,005	1,233	1,451	1,385	1,234	967
Total Revenue	1,345	1,281	1,338	1,418	1,502	1,526	1,870	2,252	2,142	1,965	1,978
Operating Revenue	1,345	1,281	1,338	1,418	1,502	1,526	1,870	2,252	2,142	1,965	1,978
Total Cost of Revenue	480	454	493	495	501	521	638	801	757	732	1,011
Operating Cost of Revenue	480	454	493	495	501	521	638	801	757	732	1,011
Total Operating Expenses	704	647	746	769	734	1,031	846	821	853	824	870
Selling, General & Admin Expense	127	-	-	102	105	112	112	128	130	119	113
Marketing Expense	376	360	376	376	392	392	414	456	474	460	451
Research & Development Expense	164	147	150	154	162	157	149	190	190	199	193
Amortization Expense	37	39	39	39	39	30	21	19	15	11	9.60
Restructuring Charge	-	102	181	98	29	200	151	28	45	35	102
Total Other Income / (Expense), net	-42	-43	-42	-39	-41	-52	53	-4.25	-19	20	23
Interest Expense	39	37	39	50	67	74	71	54	58	53	44
Interest & Investment Income	3.96	4.75	6.78	11	21	22	10	9.56	33	79	68
Other Income / (Expense), net	-6.94	-11	-9.67	-0.00	5.60	0.43	114	41	6.74	-5.71	-0.74
Income Tax Expense	2.46	6.40	-23	74	35	-36	80	113	89	89	38
Basic Earnings per Share	$0.50	$0.56	$0.34	$0.18	$0.84	($0.18)	$1.57	$2.25	$1.86	$1.50	$0.38
Weighted Average Basic Shares Outstanding	232.64M	233.48M	234.80M	228.07M	226.64M	226.78M	228.43M	227.98M	227.58M	228.15M	222.62M
Diluted Earnings per Share	$0.48	$0.55	$0.34	$0.17	$0.82	($0.18)	$1.53	$2.21	$1.84	$1.48	$0.37
Weighted Average Diluted Shares Outstanding	242.81M	238.65M	238.99M	233.01M	233.46M	226.78M	234.21M	232.03M	230.14M	230.62M	224.72M
Weighted Average Basic & Diluted Shares Outstanding	232.02M	233.01M	234.56M	226.56M	225.51M	227.75M	227.99M	227.07M	227.72M	228.20M	222.29M

No quarterly income statements for Qiagen are available.

This table details how cash moves in and out of Qiagen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	62	-103	149	219	501	-530	-31	283	-150	-63	-4.53
Net Cash From Operating Activities	288	317	342	287	359	331	458	639	715	459	674
Net Cash From Continuing Operating Activities	288	317	342	287	359	331	458	639	715	459	674
Net Income / (Loss) Continuing Operations	117	130	80	40	190	-41	359	513	423	341	84
Consolidated Net Income / (Loss)	117	130	80	40	190	-41	359	513	423	341	84
Depreciation Expense	201	191	213	216	206	231	205	215	208	205	203
Amortization Expense	15	20	20	25	36	41	42	32	34	30	18
Non-Cash Adjustments To Reconcile Net Income	75	42	90	36	46	210	-70	14	91	59	256
Changes in Operating Assets and Liabilities, net	-120	-66	-62	-31	-118	-110	-79	-135	-41	-176	112
Net Cash From Investing Activities	-408	-146	-179	-464	-211	-222	-443	-202	-727	-88	-249
Net Cash From Continuing Investing Activities	-408	-146	-179	-464	-211	-222	-443	-202	-727	-88	-249
Purchase of Property, Plant & Equipment	-87	-98	-75	-90	-110	-118	-133	-190	-129	-150	-167
Acquisitions	-171	-87	-110	-85	-214	-225	-411	-17	-84	-163	-4.07
Purchase of Investments	-430	-324	-520	-455	-577	-294	-50	-400	-1,387	-979	-688
Sale and/or Maturity of Investments	276	368	534	189	692	391	207	360	883	1,271	585
Other Investing Activities, net	3.61	-5.98	-8.80	-23	-19	23	-58	45	-9.77	-67	25
Net Cash From Financing Activities	193	-259	-11	387	360	-639	-50	-150	-126	-434	-423
Net Cash From Continuing Financing Activities	193	-259	-11	387	360	-639	-50	-150	-126	-434	-423
Repayment of Debt	-392	-253	-18	140	486	-518	-365	-43	-480	-400	-602
Repurchase of Common Equity	-127	-21	0.00	-61	-105	-74	-239	-100	0.00	0.00	-292
Issuance of Debt	733	1.59	0.00	330	0.00	0.00	557	0.00	371	0.00	494
Other Financing Activities, net	-103	3.33	0.78	-74	-97	-49	-11	-15	-17	-34	-23
Effect of Exchange Rate Changes	-11	-15	-2.77	8.83	-7.18	0.83	4.20	-3.68	-13	-0.56	-5.96
Cash Interest Paid	24	21	18	20	26	30	25	22	23	20	24
Cash Income Taxes Paid	13	34	23	40	29	41	43	102	120	82	16

No quarterly cash flow statements for Qiagen are available.

This table presents Qiagen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	4,454	4,179	4,308	5,039	5,748	5,264	5,928	6,147	6,288	6,115	5,690
Total Current Assets	1,149	961	1,038	1,648	2,155	1,512	1,599	2,110	2,394	2,148	1,960
Cash & Equivalents	393	290	439	658	1,159	622	597	881	731	668	664
Short-Term Investments	184	131	93	359	235	108	14	185	688	390	489
Accounts Receivable	265	274	278	329	352	376	381	362	324	382	349
Inventories, net	132	137	137	156	163	171	291	328	358	398	279
Prepaid Expenses	114	70	67	99	109	-	-	355	294	310	178
Plant, Property, & Equipment, net	428	443	437	494	512	356	427	638	662	765	754
Total Noncurrent Assets	2,878	2,775	2,834	2,896	3,082	3,396	3,902	3,399	3,232	3,203	2,976
Goodwill	1,888	1,876	1,926	2,013	2,109	2,166	2,389	2,351	2,353	2,476	2,425
Intangible Assets	727	636	557	499	475	751	884	627	545	527	304
Other Noncurrent Operating Assets	258	261	283	345	455	392	529	421	334	200	247
Total Liabilities & Shareholders' Equity	4,454	4,179	4,308	5,039	5,748	5,264	5,928	6,147	6,288	6,115	5,690
Total Liabilities	1,796	1,611	1,701	2,498	3,113	2,940	3,445	3,050	2,821	2,307	2,122
Total Current Liabilities	432	268	308	325	972	951	571	1,517	975	1,079	544
Short-Term Debt	131	-	-	0.00	503	285	43	848	390	588	53
Accounts Payable	46	52	51	59	69	85	118	101	99	84	83
Accrued Expenses	224	192	230	242	263	-	-	569	486	407	407
Total Noncurrent Liabilities	1,365	1,343	1,393	2,173	2,141	1,989	2,874	1,533	1,847	1,228	1,579
Long-Term Debt	1,041	1,049	1,067	1,758	1,671	1,419	1,875	1,094	1,472	922	1,338
Other Noncurrent Operating Liabilities	207	224	285	338	407	542	953	439	375	306	241
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	-	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,658	2,568	2,607	2,541	2,635	3,159	3,199	3,097	3,467	3,808	3,567
Total Preferred & Common Equity	2,650	2,566	2,607	2,541	2,635	2.70	2.70	3,097	3,467	3,808	3,567
Total Common Equity	2,650	2,566	2,607	2,541	2,635	1,368	1,359	3,097	3,467	3,808	3,567
Common Stock	1,826	1,768	1,797	1,633	1,745	2.70	2.70	1,821	1,871	1,918	1,669
Retained Earnings	1,126	1,209	1,263	1,248	1,380	948	998	1,792	2,160	2,457	2,448
Treasury Stock	-167	-152	-120	-119	-179	112	118	-190	-160	-133	-75
Accumulated Other Comprehensive Income / (Loss)	-135	-259	-334	-221	-311	-	-	-327	-404	-434	-475

No quarterly balance sheets for Qiagen are available.

This table displays calculated financial ratios and metrics derived from Qiagen's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.29%	-4.74%	4.45%	5.95%	5.95%	1.64%	22.53%	20.39%	-4.89%	-8.23%	0.66%
EBITDA Growth	39.83%	2.55%	-15.17%	22.31%	30.29%	-52.05%	203.46%	22.71%	-15.00%	-18.02%	-50.19%
EBIT Growth	134.76%	9.17%	-47.23%	72.08%	77.41%	-109.44%	2,048.17%	33.95%	-19.76%	-24.89%	-76.01%
NOPAT Growth	35.13%	8.02%	-18.48%	-61.15%	314.94%	-108.14%	1,826.34%	63.40%	-14.98%	-25.81%	-79.29%
Net Income Growth	69.23%	11.09%	-38.18%	-49.70%	371.31%	-121.77%	966.45%	42.71%	-17.44%	-19.35%	-75.51%
EPS Growth	69.23%	11.09%	-38.18%	-50.00%	382.35%	-121.95%	950.00%	42.71%	-17.44%	-19.35%	-75.51%
Operating Cash Flow Growth	11.20%	10.26%	7.59%	-16.05%	25.36%	-7.97%	38.38%	39.58%	11.93%	-35.76%	46.60%
Free Cash Flow Firm Growth	530.07%	142.43%	-15.10%	-144.47%	206.42%	142.61%	-176.77%	219.73%	145.57%	-104.87%	2,231.49%
Invested Capital Growth	2.01%	-1.76%	-1.70%	4.47%	4.06%	-7.05%	15.33%	8.51%	-1.59%	8.95%	-10.66%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.34%	64.53%	63.13%	65.08%	66.65%	65.86%	65.91%	64.43%	64.65%	62.77%	48.90%
EBITDA Margin	27.58%	29.69%	24.12%	27.84%	34.23%	16.15%	40.00%	40.77%	36.44%	32.55%	16.11%
Operating Margin	12.02%	14.01%	7.39%	10.82%	17.75%	-1.71%	20.66%	27.98%	24.82%	20.86%	4.94%
EBIT Margin	11.51%	13.19%	6.66%	10.82%	18.12%	-1.68%	26.77%	29.79%	25.13%	20.57%	4.90%
Profit (Net Income) Margin	8.70%	10.14%	6.00%	2.85%	12.68%	-2.72%	19.20%	22.77%	19.76%	17.37%	4.23%
Tax Burden Percent	97.94%	95.30%	141.11%	35.32%	84.34%	53.30%	81.73%	81.91%	82.56%	79.41%	69.00%
Interest Burden Percent	77.15%	80.68%	63.83%	74.55%	82.94%	302.58%	87.76%	93.30%	95.24%	106.33%	124.93%
Effective Tax Rate	2.06%	4.70%	-41.11%	64.68%	15.66%	0.00%	18.27%	18.09%	17.44%	20.59%	31.00%
Return on Invested Capital (ROIC)	4.92%	5.30%	4.40%	1.69%	6.71%	-0.56%	9.24%	13.52%	11.13%	7.97%	1.67%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.90%	-1.42%	-5.77%	-0.47%	2.19%	-6.37%	27.37%	13.00%	8.77%	11.49%	6.36%
Return on Net Nonoperating Assets (RNNOA)	-0.57%	-0.33%	-1.30%	-0.12%	0.64%	-0.88%	2.06%	2.77%	1.76%	1.41%	0.60%
Return on Equity (ROE)	4.35%	4.97%	3.10%	1.57%	7.36%	-1.43%	11.30%	16.28%	12.90%	9.38%	2.27%
Cash Return on Invested Capital (CROIC)	2.92%	7.08%	6.11%	-2.68%	2.74%	6.75%	-5.00%	5.36%	12.74%	-0.60%	12.93%
Operating Return on Assets (OROA)	3.62%	3.91%	2.10%	3.28%	5.05%	-0.47%	8.95%	11.11%	8.66%	6.52%	1.64%
Return on Assets (ROA)	2.74%	3.01%	1.89%	0.86%	3.53%	-0.75%	6.42%	8.49%	6.81%	5.50%	1.42%
Return on Common Equity (ROCE)	4.33%	4.96%	3.10%	1.57%	7.36%	-0.99%	4.85%	11.52%	12.90%	9.38%	2.27%
Return on Equity Simple (ROE_SIMPLE)	4.41%	5.06%	3.08%	1.59%	7.23%	-1,534.23%	0.00%	16.55%	12.21%	8.96%	2.34%
Net Operating Profit after Tax (NOPAT)	158	171	139	54	225	-18	316	516	439	326	67
NOPAT Margin	11.78%	13.35%	10.42%	3.82%	14.97%	-1.20%	16.89%	22.92%	20.49%	16.56%	3.41%
Net Nonoperating Expense Percent (NNEP)	7.81%	6.73%	10.17%	2.16%	4.53%	5.82%	-18.13%	0.52%	2.36%	-3.53%	-4.68%
Return On Investment Capital (ROIC_SIMPLE)	4.13%	4.73%	3.80%	1.26%	4.68%	-0.38%	6.17%	10.24%	8.24%	6.12%	1.36%
Cost of Revenue to Revenue	35.66%	35.47%	36.87%	34.92%	33.35%	34.14%	34.09%	35.57%	35.35%	37.23%	51.10%
SG&A Expenses to Revenue	9.42%	0.00%	0.00%	7.20%	6.96%	7.35%	5.97%	5.69%	6.06%	6.07%	5.73%
R&D to Revenue	12.17%	11.46%	11.20%	10.87%	10.78%	10.31%	7.97%	8.44%	8.87%	10.10%	9.78%
Operating Expenses to Revenue	52.31%	50.52%	55.74%	54.26%	48.90%	67.57%	45.25%	36.45%	39.84%	41.91%	43.96%
Earnings before Interest and Taxes (EBIT)	155	169	89	153	272	-26	501	671	538	404	97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	371	380	323	395	514	247	748	918	780	640	319
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.90	2.29	2.29	2.62	2.71	5.10	8.12	3.75	2.99	2.38	2.77
Price to Tangible Book Value (P/TBV)	144.20	109.03	48.08	231.03	139.16	0.00	0.00	98.10	18.23	11.25	11.79
Price to Revenue (P/Rev)	3.74	4.59	4.47	4.69	4.76	4.58	5.90	5.16	4.85	4.61	4.99
Price to Earnings (P/E)	43.21	45.17	74.40	164.57	37.56	0.00	30.71	22.65	24.52	26.55	118.17
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.31%	2.21%	1.34%	0.61%	2.66%	0.00%	3.26%	4.41%	4.08%	3.77%	0.85%
Enterprise Value to Invested Capital (EV/IC)	1.73	2.04	2.07	2.25	2.32	3.07	3.87	3.14	2.77	2.23	2.66
Enterprise Value to Revenue (EV/Rev)	4.19	5.08	4.87	5.21	5.28	6.38	7.57	5.55	5.05	4.84	5.11
Enterprise Value to EBITDA (EV/EBITDA)	15.18	17.11	20.20	18.72	15.43	39.48	18.93	13.60	13.87	14.87	31.75
Enterprise Value to EBIT (EV/EBIT)	36.39	38.52	73.10	48.16	29.14	0.00	28.29	18.62	20.10	23.54	104.33
Enterprise Value to NOPAT (EV/NOPAT)	35.56	38.05	46.73	136.37	35.28	0.00	44.85	24.20	24.66	29.23	150.06
Enterprise Value to Operating Cash Flow (EV/OCF)	19.56	20.50	19.08	25.77	22.06	29.42	30.94	19.54	15.13	20.71	15.02
Enterprise Value to Free Cash Flow (EV/FCFF)	59.83	28.52	33.64	0.00	86.52	43.76	0.00	61.08	21.55	0.00	19.41
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.44	0.41	0.41	0.69	0.83	0.54	0.60	0.63	0.54	0.40	0.39
Long-Term Debt to Equity	0.39	0.41	0.41	0.69	0.63	0.45	0.59	0.35	0.42	0.24	0.38
Financial Leverage	0.20	0.23	0.22	0.25	0.29	0.14	0.08	0.21	0.20	0.12	0.09
Leverage Ratio	1.59	1.65	1.64	1.82	2.08	1.90	1.76	1.92	1.89	1.71	1.60
Compound Leverage Factor	1.22	1.33	1.05	1.35	1.73	5.75	1.55	1.79	1.80	1.81	2.00
Debt to Total Capital	30.60%	29.00%	29.04%	40.90%	45.21%	35.04%	37.48%	38.54%	34.94%	28.39%	28.06%
Short-Term Debt to Total Capital	3.42%	0.00%	0.00%	0.00%	10.46%	5.87%	0.83%	16.82%	7.31%	11.06%	1.08%
Long-Term Debt to Total Capital	27.18%	29.00%	29.04%	40.90%	34.75%	29.17%	36.65%	21.72%	27.63%	17.34%	26.98%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	36.82%	35.96%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.22%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	69.18%	70.94%	70.96%	59.10%	54.79%	28.14%	26.56%	61.46%	65.06%	71.61%	71.94%
Debt to EBITDA	3.16	2.76	3.31	4.46	4.23	6.91	2.56	2.12	2.39	2.36	4.37
Net Debt to EBITDA	1.61	1.65	1.66	1.88	1.52	3.89	1.73	0.95	0.57	0.71	0.75
Long-Term Debt to EBITDA	2.81	2.76	3.31	4.46	3.25	5.75	2.51	1.19	1.89	1.44	4.20
Debt to NOPAT	7.40	6.13	7.65	32.45	9.67	-93.13	6.07	3.76	4.24	4.64	20.64
Net Debt to NOPAT	3.76	3.67	3.84	13.68	3.47	-52.37	4.10	1.70	1.01	1.39	3.54
Long-Term Debt to NOPAT	6.57	6.13	7.65	32.45	7.43	-77.54	5.94	2.12	3.35	2.83	19.85
Altman Z-Score	2.64	3.23	3.10	2.64	2.38	2.08	2.96	3.53	3.58	3.67	4.10
Noncontrolling Interest Sharing Ratio	0.33%	0.20%	0.04%	0.00%	0.00%	30.90%	57.11%	29.23%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.66	3.58	3.36	5.07	2.22	1.59	2.80	1.39	2.46	1.99	3.61
Quick Ratio	1.95	2.59	2.63	4.14	1.80	1.16	1.74	0.94	1.79	1.33	2.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	94	228	194	-86	92	222	-171	204	502	-24	521
Operating Cash Flow to CapEx	332.69%	325.05%	458.69%	318.51%	327.49%	280.49%	344.77%	336.49%	553.51%	306.90%	402.90%
Free Cash Flow to Firm to Interest Expense	2.39	6.10	4.96	-1.73	1.36	3.00	-2.39	3.75	8.60	-0.46	11.89
Operating Cash Flow to Interest Expense	7.32	8.49	8.75	5.77	5.34	4.46	6.42	11.73	12.26	8.60	15.36
Operating Cash Flow Less CapEx to Interest Expense	5.12	5.88	6.85	3.96	3.71	2.87	4.56	8.24	10.04	5.80	11.55
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.31	0.30	0.32	0.30	0.28	0.28	0.33	0.37	0.34	0.32	0.34
Accounts Receivable Turnover	5.12	4.75	4.85	4.67	4.41	4.19	4.94	6.06	6.24	5.57	5.41
Inventory Turnover	3.68	3.38	3.61	3.38	3.14	3.12	2.76	2.59	2.21	1.93	2.98
Fixed Asset Turnover	3.08	2.94	3.04	3.05	2.99	3.52	4.77	4.23	3.29	2.75	2.61
Accounts Payable Turnover	9.89	9.23	9.53	8.97	7.79	6.76	6.28	7.30	7.57	8.00	12.08
Days Sales Outstanding (DSO)	71.24	76.80	75.31	78.20	82.72	87.03	73.85	60.19	58.45	65.53	67.45
Days Inventory Outstanding (DIO)	99.08	108.00	101.04	107.84	116.17	116.83	132.20	140.99	165.27	188.67	122.34
Days Payable Outstanding (DPO)	36.91	39.54	38.30	40.71	46.86	53.99	58.08	49.99	48.21	45.62	30.23
Cash Conversion Cycle (CCC)	133.41	145.26	138.05	145.32	152.03	149.86	147.97	151.19	175.51	208.57	159.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,253	3,196	3,142	3,282	3,415	3,175	3,661	3,973	3,910	4,260	3,806
Invested Capital Turnover	0.42	0.40	0.42	0.44	0.45	0.46	0.55	0.59	0.54	0.48	0.49
Increase / (Decrease) in Invested Capital	64	-57	-54	140	133	-241	487	312	-63	350	-454
Enterprise Value (EV)	5,631	6,509	6,517	7,389	7,932	9,733	14,165	12,487	10,819	9,514	10,117
Market Capitalization	5,028	5,878	5,982	6,648	7,151	6,984	11,029	11,611	10,376	9,062	9,878
Book Value per Share	$11.33	$11.06	$11.19	$10.83	$11.63	$6.07	$5.97	$13.58	$15.23	$16.72	$15.63
Tangible Book Value per Share	$0.15	$0.23	$0.53	$0.12	$0.23	($6.87)	($8.40)	$0.52	$2.50	$3.54	$3.67
Total Capital	3,830	3,617	3,674	4,299	4,809	4,863	5,117	5,038	5,328	5,318	4,959
Total Debt	1,172	1,049	1,067	1,758	2,174	1,704	1,918	1,942	1,861	1,510	1,392
Total Long-Term Debt	1,041	1,049	1,067	1,758	1,671	1,419	1,875	1,094	1,472	922	1,338
Net Debt	595	628	535	741	781	958	1,296	876	443	452	239
Capital Expenditures (CapEx)	87	98	74	90	110	118	133	190	129	150	167
Debt-free, Cash-free Net Working Capital (DFCFNWC)	272	272	197	306	292	109	459	374	391	598	317
Debt-free Net Working Capital (DFNWC)	848	693	729	1,323	1,686	846	1,070	1,440	1,809	1,656	1,470
Net Working Capital (NWC)	717	693	729	1,323	1,183	560	1,028	592	1,419	1,068	1,416
Net Nonoperating Expense (NNE)	41	41	59	14	34	23	-43	3.48	16	-16	-16
Net Nonoperating Obligations (NNO)	595	628	535	741	781	16	463	876	443	452	239
Total Depreciation and Amortization (D&A)	216	211	234	241	242	272	247	247	242	235	222
Debt-free, Cash-free Net Working Capital to Revenue	20.19%	21.25%	14.72%	21.61%	19.46%	7.17%	24.56%	16.63%	18.24%	30.45%	16.01%
Debt-free Net Working Capital to Revenue	63.08%	54.10%	54.50%	93.34%	112.26%	55.39%	57.23%	63.94%	84.47%	84.27%	74.29%
Net Working Capital to Revenue	53.33%	54.10%	54.50%	93.34%	78.76%	36.71%	54.96%	26.30%	66.28%	54.36%	71.59%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.53	$0.57	$0.36	$0.19	$0.89	($0.19)	$0.00	$0.00	$1.97	$1.54	$0.38
Adjusted Weighted Average Basic Shares Outstanding	219.16M	219.95M	221.43M	215.09M	213.73M	213.86M	0.00	0.00	214.62M	221.81M	222.62M
Adjusted Diluted Earnings per Share	$0.51	$0.57	$0.36	$0.18	$0.87	($0.19)	$0.00	$0.00	$1.95	$1.52	$0.37
Adjusted Weighted Average Diluted Shares Outstanding	227.54M	223.42M	225.38M	219.74M	220.16M	213.86M	0.00	0.00	217.03M	224.21M	224.72M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	218.58M	219.50M	221.20M	213.66M	212.67M	214.78M	0.00	0.00	214.75M	221.86M	222.29M
Normalized Net Operating Profit after Tax (NOPAT)	158	268	196	176	256	220	439	539	476	354	138
Normalized NOPAT Margin	11.78%	20.95%	14.62%	12.42%	17.03%	14.38%	23.49%	23.93%	22.22%	17.99%	6.97%
Pre Tax Income Margin	8.88%	10.64%	4.25%	8.07%	15.03%	-5.10%	23.50%	27.79%	23.94%	21.87%	6.12%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.93	4.52	2.28	3.09	4.04	-0.35	7.02	12.31	9.22	7.57	2.21
NOPAT to Interest Expense	4.03	4.57	3.57	1.09	3.34	-0.25	4.43	9.47	7.52	6.09	1.54
EBIT Less CapEx to Interest Expense	1.73	1.91	0.38	1.28	2.41	-1.94	5.16	8.83	7.01	4.77	-1.60
NOPAT Less CapEx to Interest Expense	1.83	1.96	1.67	-0.72	1.71	-1.84	2.57	5.99	5.30	3.29	-2.28
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	108.51%	16.03%	0.00%	150.94%	54.99%	-179.59%	66.43%	19.51%	0.00%	0.00%	349.44%

No quarterly metrics and ratios for Qiagen are available.

Frequently Asked Questions About Qiagen's Financials

When does Qiagen's financial year end?

According to the most recent income statement we have on file, Qiagen's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Qiagen's net income changed over the last 10 years?

Qiagen's net income appears to be on an upward trend, with a most recent value of $83.59 million in 2024, falling from $116.93 million in 2014. The previous period was $341.30 million in 2023.

What is Qiagen's operating income?

Qiagen's total operating income in 2024 was $97.71 million, based on the following breakdown:

Total Gross Profit: $967.35 million
Total Operating Expenses: $869.64 million

How has Qiagen revenue changed over the last 10 years?

Over the last 10 years, Qiagen's total revenue changed from $1.34 billion in 2014 to $1.98 billion in 2024, a change of 47.1%.

How much debt does Qiagen have?

Qiagen's total liabilities were at $2.12 billion at the end of 2024, a 8.0% decrease from 2023, and a 18.1% increase since 2014.

How much cash does Qiagen have?

In the past 10 years, Qiagen's cash and equivalents has ranged from $290.01 million in 2015 to $1.16 billion in 2018, and is currently $663.56 million as of their latest financial filing in 2024.

How has Qiagen's book value per share changed over the last 10 years?

Over the last 10 years, Qiagen's book value per share changed from 11.33 in 2014 to 15.63 in 2024, a change of 38.0%.

Related Companies

This page (NYSE:QGEN) was last updated on 4/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Qiagen (QGEN) Financials

Frequently Asked Questions About Qiagen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Qiagen (QGEN) Financials

Annual Income Statements for Qiagen

Quarterly Income Statements for Qiagen

Annual Cash Flow Statements for Qiagen

Quarterly Cash Flow Statements for Qiagen

Annual Balance Sheets for Qiagen

Quarterly Balance Sheets for Qiagen

Annual Metrics and Ratios for Qiagen

Quarterly Metrics and Ratios for Qiagen

Frequently Asked Questions About Qiagen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools